Login / Signup

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only.

Ching-Chun LiTsung-Kun ChangYen-Cheng ChenHsiang-Lin TsaiChing-Wen HuangWei-Chih SuCheng-Jen MaTzu-Chieh YinPo-Jung ChenJaw-Yuan Wang
Published in: Cancer management and research (2022)
polymorphism could confer such patients with comparable outcomes to that of patients with LiM-only and LuM-only mCRC.
Keyphrases
  • metastatic colorectal cancer
  • open label
  • randomized controlled trial
  • metabolic syndrome
  • skeletal muscle
  • glycemic control